Form 4 Filing for Journey Medical Corp

Michael Cooper, a director at Journey Medical Corp, was granted 10,000 restricted stock units on June 25, 2026. These units will vest on June 25, 2027. This grant is part of the Issuer's 2015 Stock Plan, as amended. Following this transaction, Mr. Cooper holds 67,173 shares, which includes other unvested restricted stock units vesting over various periods. The transaction code A indicates an acquisition, and the price per share was $0.00, suggesting these were granted as an award.